Purchase of Medicines: Alteplase, Tobramycin, and Zoledronic Acid

This procurement contract involves the purchase of medicines containing alteplase, tobramycin, and zoledronic acid. A detailed description of the procurement items can be found in the document titled 'Appendix 1: Technical Description'. The result of this procurement will be a framework agreement with one supplier for a duration of 12 months (with the sales period for part 1 starting from the signing date and for parts 2 and 3 starting from November 1, 2025). No separate contracts will be signed under the framework agreements; instead, the execution of the framework agreement will occur based on orders. The unit prices for the medicines submitted in the bid will remain valid throughout the duration of the framework agreement. For disqualification grounds and qualification conditions, please refer to the procurement documents.